ASP Isotopes (ASPI) EBIAT (2022 - 2025)
ASP Isotopes has reported EBIAT over the past 4 years, most recently at -$63.3 million for Q4 2025.
- On a quarterly basis, EBIAT fell 586.79% to -$63.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$159.8 million, a 392.99% decrease, with the full-year FY2025 number at -$159.8 million, down 392.99% from a year prior.
- EBIAT reached -$63.3 million in Q4 2025 per ASPI's latest filing, down from -$12.9 million in the prior quarter.
- The five-year high for EBIAT was -$827170.0 in Q2 2022, with the low at -$75.2 million in Q2 2025.
- The 4-year median for EBIAT is -$5.6 million (2023), against an average of -$13.3 million.
- The largest YoY upside for EBIAT was 21.49% in 2025 against a maximum downside of 746.23% in 2025.
- Tracing ASPI's EBIAT over 4 years: stood at -$1.3 million in 2022, then crashed by 219.77% to -$4.2 million in 2023, then tumbled by 121.12% to -$9.2 million in 2024, then plummeted by 586.79% to -$63.3 million in 2025.
- According to Business Quant data, EBIAT over the past three periods came in at -$63.3 million, -$12.9 million, and -$75.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.